Cargando…

Ketamine plus Alcohol: What We Know and What We Can Expect about This

Drug abuse has become a public health concern. The misuse of ketamine, a psychedelic substance, has increased worldwide. In addition, the co-abuse with alcohol is frequently identified among misusers. Considering that ketamine and alcohol share several pharmacological targets, we hypothesize that th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Natalia Harumi Correa, Farias, Sarah Viana, Luz, Diandra Araújo, Machado-Ferraro, Kissila Márvia, da Conceição, Brenda Costa, da Silveira, Cinthia Cristina Menezes, Fernandes, Luanna Melo Pereira, Cartágenes, Sabrina de Carvalho, Ferreira, Vânia Maria Moraes, Fontes-Júnior, Enéas Andrade, Maia, Cristiane do Socorro Ferraz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323326/ https://www.ncbi.nlm.nih.gov/pubmed/35887148 http://dx.doi.org/10.3390/ijms23147800

Ejemplares similares

Methylmercury plus Ethanol Exposure: How Much Does This Combination Affect Emotionality?
por: Luz, Diandra Araújo, et al.
Publicado: (2021)

Ketamine Clinical Use on the Pediatric Critically Ill Infant: A Global Bibliometric and Critical Review of Literature
por: Maia, Mary Lucy Ferraz, et al.
Publicado: (2023)

The Role of the Adenosine System on Emotional and Cognitive Disturbances Induced by Ethanol Binge Drinking in the Immature Brain and the Beneficial Effects of Caffeine
por: Pinheiro, Bruno Gonçalves, et al.
Publicado: (2022)

What We Seem and What We Are
por: Towner, Ausburn
Publicado: (1880)

Long-lasting neurocognitive disorders: a case report of previously undescribed adverse effects after ketamine sedation and analgesia in a pediatric patient
por: Machado-Ferraro, Kissila M., et al.
Publicado: (2022)

“K-Powder” Exposure during Adolescence Elicits Psychiatric Disturbances Associated with Oxidative Stress in Female Rats
por: Cartágenes, Sabrina de Carvalho, et al.
Publicado: (2022)

Are we Aware of what we are, we are what we Eat- An Epidemiological Survey
por: Kaur, Manpreet, et al.
Publicado: (2008)

Do we really measure what we think we are measuring?
por: Gordillo, Dario, et al.
Publicado: (2023)

Neurobehavioral and Antioxidant Effects of Ethanolic Extract of Yellow Propolis
por: da Silveira, Cinthia Cristina Sousa de Menezes, et al.
Publicado: (2016)

What we see depends on what we look for
por: Tomšič, Anton, et al.
Publicado: (2020)

We are what we breathe!
por: Gude, Dilip
Publicado: (2011)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Providing Oral Healthcare to Older Patients—Do We Have What It Takes?
por: da Mata, Cristiane, et al.
Publicado: (2023)

What Shall We Eat, and What Shall We Drink?
por: Cleaveland,
Publicado: (1855)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Refractive cataract surgery – what we were, what we are, and what we will be: A personal experience and perspective
por: Chen, Ming
Publicado: (2019)

The Alphavirus Exit Pathway: What We Know and What We Wish We Knew
por: Brown, Rebecca S., et al.
Publicado: (2018)

What was said about COVID-19 and what we heard and what we saw!
por: Rostami, Mojtaba, et al.
Publicado: (2021)

Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better
por: da Silveira, Fernando, et al.
Publicado: (2021)

Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005)

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

What we see and what we do not see in health care
por: Škaričić, Nataša
Publicado: (2011)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

The Etiology of Femoroacetabular Impingement: What We Know and What We Don’t
por: Chaudhry, Harman, et al.
Publicado: (2014)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

The SCOT-HEART Trial. What we observed and what we learned
por: Adamson, Philip D., et al.
Publicado: (2019)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

The Novel Coronavirus Outbreak: What We Know and What We Don’t
Publicado: (2020)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Enhancer RNA: What we know and what we can achieve
por: Han, Zhenzhen, et al.
Publicado: (2022)

What we can and what we cannot see with extracellular multielectrodes
por: Chintaluri, Chaitanya, et al.
Publicado: (2021)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Immunopathogenesis of Human Sporotrichosis: What We Already Know
por: Conceição-Silva, Fatima, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nuctum7l7a2afis5gn9672jm81